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Summary The effects of cholera toxin (CT) and 8-chloro-cAMP (8-Cl-cAMP) on cell growth were inves-
tigated using two human pancreatic carcinoma cell lines (MIA PaCa-2, Panc-1). CT, which catalyses the ADP
ribosylation of Gs, suppresses the proliferation of MIA PaCa-2(PC) cells. CT at the low dose of 0.1 pg ml '
was inhibitory ofPC cell growth, and the maximum suppression (70%) was achieved at a CT concentration of
100 pg ml-'. This phenomenon was reversible. The production of cAMP by CT (100 pg ml-') in PC cells was
enhanced 320-fold compared with the control. In addition, cAMP analogues (8-Cl-cAMP, 8-Br-cAMP) and
forskolin decreased the growth rate of PC cells in a dose-dependent manner. These results support the view
that CT suppresses PC cell growth by stimulating cAMP production. Conversely, Panc-l cells were far less
sensitive to CT in cell growth and cAMP production. 8-Cl-cAMP was also less effective on Panc-l cell growth.
The binding of an insulin-like growth factor (IGF)-I and transforming growth factor (TGF)-a, which has
been shown to stimulate PC cell growth in an autocrine manner, to PC cells was not modified in cells treated
with CT or 8-Cl-cAMP. The results suggest that the inhibitory actions of these substances do not occur at the
level of the receptor for IGF-I or EGF/TGF-a. We have previously shown that phorbol esters, which decrease
the binding ofTGF-a to PC cells, has an anti-proliferative activity on these tumour cells. Inhibited cell growth
by maximum suppressive dose of CT or 8-Cl-cAMP was further inhibited by TPA. In addition, an oncogene
product of K-ras which is commonly activated in pancreatic cancer, was increased by CT and 8-Cl-cAMP.
It is concluded that CT and 8-Cl-cAMP inhibit PC cell growth, presumably in a similar manner, and their
mechanism(s) of action may be different from that of TPA. The anti-proliferative effect of CT or 8-Cl-cAMP
was enhanced by TPA, implying that the combination of these substances results in increased inhibition of the
PC cell growth.
The bacterial exotoxin, cholera toxin (CT), is known to bind
with high affinity to monosialoganglioside GM, on the cell
surface and stimulate ADP-ribosylation of the stimulating G
protein of adenylate cyclase, Gs. Activated adenylate cyclase
eventually leads to an increase of intracellular cAMP level in
most cellular systems (Holmgren, 1981). Modulation of cel-
lular function by CT has been reported, including
modification of cell growth by the toxin. For example, CT
stimulates the growth of cultured human mammary epithelial
cells (Taylor-Papadimitriou et al., 1980), Swiss 3T3 cells
(Rozengurt et al., 1981), and epithelial cells from normal
human bronchus (Lechner et al., 1981), in the presence of
serum or growth factors. In contrast, it has also been shown
that CT inhibits TGF-,B-induced monolayer growth of
fibroblast cells (How et al., 1989) and the proliferation of
hormone-dependent rat mammary cancer cells (Cho-Chung
et al., 1983) and human small-cell lung cancer cells (Viallet et
al., 1990). Although the mechanism(s) of CT-induced cellular
events is not definitely known at present, it is believed that
increased intracellular cAMP is a participating element.
However, Viallet et al. have reported that elevation of cel-
lular cAMP alone can not account for CT-induced growth
inhibition of human small-cell lung cancer (Viallet et al.,
1990).
On the other hand, the physiological actions of cAMP, a
second messenger in a variety of extracellular signals, have
been studied widely and extensively using its analogues.
Among these analogues, 8-Cl-cAMP has been found to bind
selectively to the site 1 receptor of the type II regulatory
subunit (Cho-Chung, 1990). This site-selective cAMP ana-
logue inhibits the cell growth of human colon cancer cell
(Ally et al., 1988; Tagliaferri et al., 1988), leukemia cells
(Tortora et al., 1988), lung cancer cells (Ally et al., 1989),
gastric cancer cells (Takanashi et al., 1991), and Ki-ras-
transformed rat fibroblasts (Tortora et al., 1989).
Previously, we have shown that the growth of human
pancreatic cancer cells (MIA PaCa-2) is enhanced by trans-
forming growth factor (TGF)-x and insulin-like growth fac-
tor (IGF)-I in an autocrine manner (Ohmura et al., 1990). In
the present study, we demonstrate that CT and 8-Cl-cAMP
suppress pancreatic cancer cell growth, and the mechanism(s)
of actions of these substances was also investigated, in rela-
tion to the above two growth factors and K-ras oncogene,
where the point mutation is frequently observed in pancreatic
carcinomas (Barbacid, 1987; Barbacid, 1990).
Materials and methods
Reagents and cell culture
CT, forskolin and TPA were purchased from Sigma
Chemical Co. (St. Louis, MO). 8-Cl-cAMP was provided by
ICN Pharmaceuticals (Costa Mesa, CA).
Human pancreatic carcinoma cells (MIA PaCa-2, Panc-1)
were obtained from American Type Culture Collection
(Rockville, MD) and Japanese Cancer Research Resources
Bank (Tokyo, Japan), respectively. The cells were maintained
by once-weekly passage in Dulbecco's modified essential
medium (DMEM) containing 5% fetal calf serum (FCS,
Filtron, Australia) at 37°C in 5% C02/95% humidified air.
Proliferation study
MIA PaCa-2 cells (PC cells) and Panc-I cells were seeded
into 12-well plates (Costar, MA) at a density of 1.2-1.7 x
104 cells/well. Cultured cells were used after growing for 2
days in 5% FCS/DMEM. The cells were washed with serum-
free DMEM; the proliferation studies were then performed in
DMEM supplemented with 5% FCS (5% FCS/DMEM) or
0.3% bovine serum albumin (BSA) (0.3% BSA/DMEM).
The test materials, dissolved with 0.3% BSA/DMEM, were
added at the beginning of the experiment. Media and
materials were changed every 2 days. At the end of
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experiments (usually 4 days after adding the test materials
unless otherwise stated), cells isolated by trypsinizing were
counted using a Coulter Counter (Coulter Electronics Inc.).
The mean ± s.d. was calculated for each group and
significance was determined by the Student's t test.
Binding studies
Subconfluent cells cultured in 12-well plates were used for the
binding studies. The cells were washed once with ice-cold
0.3% BSA/DMEM supplemented with 20 mmol 1' 4-(2-
hydroxyethyl)-l-piperazine ethanesulfonic acid (pH; 7.4) and
then incubated at 4°C for 24 h in the same medium with or
without peptides. Labelled ligands (40,000-50,000 c.p.m./
well) were added and incubated at 4°C for 20 h. After remov-
ing the medium, the cells were washed twice with ice-cold
fresh medium and solubilised with 0.5 ml 1 N NaOH. Sam-
ples were transferred to tubes for radioactivity counts.
cAMP assay
Subconfluent cultured cells were incubated for 24 h with or
without CT in 0.3% BSA/DMEM containing 0.5mmoll1'
3-isobutyl-1-methyl-xanthine. The cells and medium were
then extracted with 10% TCA. The amount of cAMP in the
supernatant was determined using cAMP RIA kits (New
England Nuclear, Boston, MA).
Immunoblotting
Subconfluent PC cells cultured in 5% FCS/DMEM were
collected and suspended in 5 ml 10m mol I` Tris-HCl (pH;
7.4) containing 10% sucrose, m mol I` phenylmethylsul-
fonyl fluoride (PMSF) and 50 units ml-' aprotinin. Cells
were homogenised with a Teflon glass homogeniser, sonic-
ated for 2 min, and then centrifuged at 600 g for 10min.
Supernatants were centrifuged at 20,000 g for 40 min. The
pellets were suspended in 0.5 ml 10m mol-
1 Tris-HCl (pH;
7.4) containing 0.15 mol 1' NaCl, 0.01 mol 1-1 MaCl2, 0.5%
Nonidet P-40, m mol 1` PMSF, and 50 units ml-' apro-
tinin. The suspension was centrifuged at 20,000 g for 40 min
at 4°C. Supernatants (300 jIg protein/lane) were separated by
17% SDS-PAGE and transferred to Clear Blot Membrane-P
(Atto, Tokyo, Japan). K-ras p21 (Oncogene Science, Inc.
Manhasset, NY) was used for the control antigen. After
blocking with 3% BSA, the membranes were incubated with
monoclonal antibody to K-ras p21 (Oncogene Science, Inc.)
or normal mouse IgG for 20 h at 4°C and then incubated
with '251-labelled protein A for 16 h at 4°C. They were
exposed to an X-ray film (Fuji X-ray, Tokyo, Japan) at
- 70°C for 3-4 days. The quantitative analysis was per-
formed with Video densitometer (Nippon Bio Rad Lab.
Tokyo, Japan).
Results
Effect ofCT on growth and cAMPproduction in PC or
Panc-J cells
As shown in Figure la, CT suppressed PC cell growth in the
absence (0.3% BSA) or presence of 5% FCS. Half the max-
imum suppressive dose (IC50) of CT was between 10-100 pg
ml-'. The inhibitory effect of the toxin appears to be reversi-
ble because PC cells grew again after the elimination of CT
in the medium (Figure 2). In contrast, CT was far less
effective on the cell growth of Panc-1 cells, another pan-
creatic cancer cell line (Figure lb). It is generally assumed
that the action of CT is attributed in part to cAMP
stimulated by the toxin. To address this possibility, we
observed the cAMP production of these two kinds of cells
exposed to CT. As shown in Figure 3, at low levels of
1 pg ml-' CT was able to stimulate cAMP production in PC
cells. At a concentration of 100 pg ml-' of the toxin, the
production of cAMP was enhanced 320-fold (control;
16.4 ± 0.8 nmol l-', CT 100 pgml1'; 5230 + 456 nmol l-').
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Figure la,b Effect of CT on pancreatic cell growth (a MIA
PaCa-2 cells (PC cells), b Panc-l cells). Cells were cultured in 5%
FCS/DMEM for 2 days. After removing the medium, cells were
incubated with CT in 5% FCS/DMEM or 0.3% BSA/DMEM
for 4 days. Medium and the test material were changed every 2
days. Values are means + s.d. -(bars) of three determinations.
(*P<0.01).
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Figure 2 Time-course study of CT-induced suppression of PC
(MIA PaCa-2) cell growth. Cells cultured with 5% FCS/DMEM
were exposed to CT for 4 days. CT was then eliminated from the
medium. Medium and test materials were changed every 2 days.
(0-0; control, * 0; CT lOpgmlh', 0 0; lOOpgml-').
Values are means± s.d. (bars) of three determinations. Points
without bars include s.d. in the symbols.
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Figure 3 Effect of CT on cAMP production ofPC cells (0-0)
and Panc-l cells (@-@). For details see 'Materials and
methods'. Values are means ± s.d. (bars) of three determinations.
Panc-1 cells, however, were less sensitive to CT in cAMP
production (control; 14.3 ± 2.2 nmol l-1, CT 100 pg ml-';
1408 ± 89 nmol 1-l).
Effects ofcAMP analogues andforskolin on cellgrowth ofPC
cells
To clarify the mechanism of the growth-inhibitory effect of
CT, the growth responses to cAMP analogues were inves-
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tigated. 8-Cl-cAMP markedly suppressed the proliferation of
PC cells cultured in 5% FCS/DMEM to 14% of control
values (IC5o; 10-50jsmol 1-1; Figure 4a). This effect was also
observed in PC cells cultured in serum-free medium (0.3%
BSA/DMEM). Similarly, 8-Br-cAMP, another cAMP
analogue, also had an inhibitory action (IC5o; 1 mmolI`),
although it was less potent than 8-Cl-cAMP (data not
shown). Furthermore, forskolin, which elevates the intracel-
lular cAMP level, was able to suppress PC cell growth in a
dose-responsive manner (Figure 4b). However, 8-Cl-cAMP
was far less effective in Panc-1 cell growth (data not shown).
Effect ofCTand8-Cl-cAMP on EGFor IGF-I binding to PC
cells
We have reported that TGF-o and IGF-I act as growth
stimulators of PC cells in an autocrine fashion. To investigate
the roles of these two growth factors in the inhibitory effect
of CT or 8-Cl-cAMP, we measured the binding of '25I-EGF
and '25I-IGF-I to cells treated with CT or 8-Cl-cAMP. How-
ever, they did not have substantial effects on the bindings of
the growth factors to PC cells exposed to CT or 8-Cl-cAMP.
A similar phenomenon was noted in Panc-l cells exposed to
8-Cl-cAMP (data not shown).
Effect ofCTand8-Cl-cAMP on levels ofK-ras p21 in PC
cells
It has been suggested that mutated ras p21, a product of the
ras oncogene, is responsible for the development of many
types of cancer. In particular, the point mutation of K-ras
oncogene is frequently (80%-90%) observed in human pan-
creatic cancer. This prompted us to examine whether K-ras
p21 is modulated or not in PC cells treated by CT or
8-Cl-cAMP. As shown in Figure 5a and b, the level of K-ras
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Figure 4a,b Effects of 8-Cl-cAMP a, and forskolin b, on PC cell
growth. Experiments were performed as described in Figure 1.
Cells were exposed to the materials for 4 days, the cell number
was then counted. Values are means + s.d. (bars) of three deter-
minations. (*; P<0.01 vs control).
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Figure 5a,b Effects of 8-Cl-cAMP and CT on K-ras p21 protein
levels in PC cells analysed by Western blotting a. Quantitative
analysis by a densitometer was shown in b. Cells were exposed to
8-Cl-cAMP (200 1mol -') or CT (I ngml-') for 24 h and 72h.
Protein (300ytg/lane) was used for the analysis. The data are
representative of three separate experiments. For details, see
'Materials and methods'.
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Figure 6 Interaction between CT, 8-Cl-cAMP, and TPA in PC
cell growth. Experiments were done as described in Figure 1. The
indicated concentrations of the materials were added to the
medium simultaneously. Cells were counted after 4 days.
(*; P<0.01). Values are means + s.d. (bars) of three determina-
tions.
p21 was increased in the cells exposed to CT or 8-Cl-cAMP
for 24 h. Even at 72 h, these substances did not suppress the
protein levels. When normal IgG was used instead of anti-K-
ras antibody, no bands were observed (data not shown).
Combined effects of CT, 8-Ct-cAMP, andphorbol ester on PC
cell growth
We have previously shown that phorbol ester, an activator of
protein kinase-C, also has the ability to suppress the pro-
liferation of PC cells (Ohmura et al., 1990). To investigate
the additive or synergistic effect of CT, 8-Cl-cAMP, and
phorbol ester (TPA), maximum suppressive doses of two of
these substances were added to the medium simultaneously,
and the interactions between the substances were examined.
Figure 6 shows the result, demonstrating that PC cell growth
was most strongly inhibited by 8-Cl-cAMP, which was fur-
ther enhanced by TPA, but not CT. Similarly, CT-induced
growth inhibition was further suppressed by TPA.
Discussion
We have demonstrated that CT and 8-Cl-cAMP have the
ability to inhibit the proliferation of PC cells. A low dose of
CT (0.1 pg ml 1') was effective and IC50 was between
10 pg ml1' and 100 pg ml1'; Panc-1 cells, however, were far
less sensitive to CT. Recently, Viallet et al. have shown that
CT inhibits the growth of small-cell lung cancers with an IC50
of 27-242 ng ml1' (Viallet et al., 1990), which is higher than
that observed in PC cells. Such a difference between the cell
types in the sensitivity of the cells to CT may be explained
partly by the difference of the expression of cellular binding
sites for CT, i.e. GM ganglioside (Viallet et al., 1990).
Although the precise mechanism of CT-induced growth
inhibition is not clear at present, it is generally assumed that
increases in cellular cAMP may be involved in the growth
inhibition by CT. However, the existence of a different
mechanism is suggested in the action of CT. Proliferation in
such conditions as small-cell lung cancer, which is sensitive to
CT, but not inhibited by cAMP analogues and forskolin,
implies that CT acts through a cAMP-independent mech-
anism (Viallet et al., 1990). In the present study, cellular
cAMP production of PC cells was stimulated by CT (Figure
3). Forksolin, which increases cellular cAMP, was also
effective in suppressing PC cell growth. Further, the addition
of 8-Cl-cAMP (Figure 4a, IC50; 10-50pmol 11) or 8-Br-
cAMP (IC_v; 1mmoll1') inhibited the growth rate of PC
cells. Such different IC,0 values may imply that the growth
inhibition is not due to high concentration of nucleotides.
Above observations suggest that the suppressive effect of CT
is mediated, at least partly, through the increase of intracel-
lular cAMP enhanced by the toxin.
Previously, we have reported that IGF-I and TGF-a act as
autocrine growth stimulators in PC cell growth (Ohmura et
al., 1990). This prompted us to determine whether the recep-
tors for these growth factors are modified by CT or 8-Cl-
cAMP. The results showed that CT and 8-Cl-cAMP had no
substantial effects on the bindings of these peptide to PC
cells, suggesting that the growth inhibition by CT or 8-Cl-
cAMP does not occur at the binding sites of IGF-I or
TGF-a. With regard to EGF/TGF-o receptor, it has been
reported that 8-Cl-cAMP does not modify EGF-receptor
mRNA in human gastric carcinoma cell lines (Takanashi et
al., 1991), which is consistent with our own observations.
The ras oncogenes, which are associated with many types
of tumours, acquire their transforming property either by
single point mutations or over-expression of the normal ras
p21 (Barbacid, 1987; Barbacid, 1990). In particular, act-
ivating mutations of the K-ras gene at codons 12, 13, or 61,
have been frequently (90%) observed in human pancreatic
cancers, and it is a higher rate than those found in other
human tumours. Although the functional roles of activated
K-ras oncogenes are not clear, it has been speculated that the
oncogene products play important roles in signal transduc-
tions because of their structural and biochemical similarities
to G protein (Barbacid, 1987; Barbacid, 1990). When
antibodies specific for amino acid 12 of v-Ki-ras protein are
microinjected into cells transformed by this protein, the cells
transiently reverse to a normal phenotype (Feramisco et al.,
1985). According to a recent report, when the expression of
the mutated ras p21 was down-regulated by anti-sense RNA,
the growth of human cancer cells was inhibited, suggesting
that the mutated p21 protein contributes to the faster growth
rate of these cells (Mukhopadhyay et al., 1991). To determine
whether CT or 8-Cl-cAMP modifies K-ras p21 production,
the protein of PC cells, in which the point mutation was also
observed at codon 12 (data not shown), was analysed by
Western blotting. Our results, however, demonstrate that CT
and 8-Cl-cAMP increased K-ras p21 at 24 h. The relationship
between 8-Cl-cAMP and ras p21 has been shown by other
investigators in different cell lines. In human lung carcinoma,
the expression of N-ras mRNA is increased by 8-Cl-cAMP at
1 h and 6 h; however, it is decreased at 7 days (Ally et al.,
1989). Also, H-ras mRNA expression was increased in gastric
cancer cells exposed to 8-Cl-cAMP for 24 h and 48 h
(Takanashi et al., 1991). Our results are consistent with these
observations. Chesa et al. have reported that terminally
differentiated cells showed stronger reactivity with antibody
against ras p21 than did rapidly proliferating cells (Chesa et
al., 1987). Thus, it may be likely that there is a relationship
between growth inhibition by CT or 8-Cl-cAMP and in-
creased K-ras p21. By contrast, there are reports which
indicate that 8-Cl-cAMP reduces the p21 level: 8-Cl-cAMP
treatment for 3 days caused reduction of p21 in breast cancer
cell lines (Taglioferri et al., 1988); 8-Cl-cAMP treatment also
decreased the levels of p21 protein in K-ras-transformed rat
fibroblasts (Tortora et al., 1989). This discrepancy may be
explained partly by differences in the cells used and/or
antibody, i.e. we employed specific anti-K-ras p21 antibody,
which did not react with either H- or N-ras p21, whereas
some investigators used an antibody that reacts with whole
p21 protein. However, the exact roles of K-ras p21 on PC
cell growth remains to be elucidated.
As already indicated, activators of protein kinase C, such
as TPA, decrease the affinity or number of EGF receptors
(Shoyab et al., 1979; Lee & Weinstein, 1978) and stimulate
the phosphorylation of the EGF receptor to inhibit its func-
tions (Iwashita & Fox, 1984; Cochet et al., 1984). We have
also shown that TPA markedly reduces the affinity of EGF/
TGF-a receptor in PC cells and possibly causes growth
inhibition by TPA (Ohmura et al., 1990). Our present study
revealed that CT and 8-Cl-cAMP did not reduce the binding
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of EGF, suggesting that these substances and TPA act
through different mechanisms. This prompted us to examine
the interaction between CT or 8-Cl-cAMP and TPA. As
shown in Figure 6, suppressed PC cell growth by almost
maximum dose of 8-Cl-cAMP was further inhibited by TPA,
but not by CT. Similarly CT-induced growth inhibition was
further suppressed by TPA. These data support the view that
the inhibitory action of CT or 8-Cl-cAMP is different from
that of TPA, and a combination of these substances streng-
thens the anti-proliferative effect of each.
In conclusion, we have shown that CT and 8-Cl-cAMP
suppress PC cell growth; the mechanism is presumably
different from that ofTPA. The finding that the action of CT
or 8-Cl-cAMP is enhanced by TPA raises the possibility that
a combination of these substances may be useful for the
growth control of malignant cells.
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